These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31067743)

  • 21. Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system.
    Lee PC; Dodart JC; Aron L; Finley LW; Bronson RT; Haigis MC; Yankner BA; Harper JW
    Mol Cell; 2013 Apr; 50(2):172-84. PubMed ID: 23499007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease-associated polyalanine expansion mutations impair UBA6-dependent ubiquitination.
    Amer-Sarsour F; Falik D; Berdichevsky Y; Kordonsky A; Eid S; Rabinski T; Ishtayeh H; Cohen-Adiv S; Braverman I; Blumen SC; Laviv T; Prag G; Vatine GD; Ashkenazi A
    EMBO J; 2024 Jan; 43(2):250-276. PubMed ID: 38177505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form.
    Liu H; Li J; Tillman B; French BA; French SW
    Exp Mol Pathol; 2014 Aug; 97(1):81-8. PubMed ID: 24893112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
    Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
    J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G; Aichem A; Groettrup M
    Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
    Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative regulation of autophagy by UBA6-BIRC6-mediated ubiquitination of LC3.
    Jia R; Bonifacino JS
    Elife; 2019 Nov; 8():. PubMed ID: 31692446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement in Fertilization and Expression of Gamete Ubiquitin-Activating Enzymes UBA1 and UBA6 in the Ascidian
    Sawada H; Inoue S; Saito T; Otsuka K; Shirae-Kurabayashi M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination.
    Buchsbaum S; Bercovich B; Ciechanover A
    Mol Biol Cell; 2012 Jan; 23(1):225-32. PubMed ID: 22072791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways.
    Schulman BA; Harper JW
    Nat Rev Mol Cell Biol; 2009 May; 10(5):319-31. PubMed ID: 19352404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ubiquitin E1 enzyme Ube1 mediates NEDD8 activation under diverse stress conditions.
    Leidecker O; Matic I; Mahata B; Pion E; Xirodimas DP
    Cell Cycle; 2012 Mar; 11(6):1142-50. PubMed ID: 22370482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway.
    Bett JS; Kanuga N; Richet E; Schmidtke G; Groettrup M; Cheetham ME; van der Spuy J
    PLoS One; 2012; 7(2):e30866. PubMed ID: 22347407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of social behavior and communication in mice lacking the Uba6-dependent ubiquitin activation system.
    Lee JY; Kwak M; Lee PC
    Behav Brain Res; 2015 Mar; 281():78-85. PubMed ID: 25523030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E1 Enzymes as Therapeutic Targets in Cancer.
    Barghout SH; Schimmer AD
    Pharmacol Rev; 2021 Jan; 73(1):1-58. PubMed ID: 33177128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
    Aichem A; Boehm AN; Catone N; Schmidtke G; Groettrup M
    Methods Enzymol; 2019; 618():229-256. PubMed ID: 30850054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
    Schmidtke G; Kalveram B; Groettrup M
    FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin Activating Enzyme UBA6 Regulates Th1 and Tc1 Cell Differentiation.
    Lee JY; An EK; Hwang J; Jin JO; Lee PCW
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBA6 Inhibition Accelerates Lysosomal TRPML1 Depletion and Exosomal Secretion in Lung Cancer Cells.
    Lee D; Lee PC; Hong JH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FAT10 attenuates hypoxia-induced cardiomyocyte apoptosis by stabilizing caveolin-3.
    Zhou Q; Peng X; Liu X; Chen L; Xiong Q; Shen Y; Xie J; Xu Z; Huang L; Hu J; Wan R; Hong K
    J Mol Cell Cardiol; 2018 Mar; 116():115-124. PubMed ID: 29438664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.